The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit
Condition: Concentration-Time Profiles in Stomach & Intestine.Interventions: Drug: Paromomycin Sulfate Fasted State; Drug: Paromomycin Sulfate Fed State; Drug: Paromomycin Sulfate w/ domperidone; Drug: Paromomycin Sulfate w/ loperamide HClSponsor: Katholieke Universiteit LeuvenRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2013 Category: Research Source Type: clinical trials
The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit
Condition: Concentration-Time Profiles in Stomach & Intestine.Interventions: Drug: Paromomycin Sulfate Fasted State; Drug: Paromomycin Sulfate Fed State; Drug: Paromomycin Sulfate w/ domperidone; Drug: Paromomycin Sulfate w/ loperamide HClSponsors: Katholieke Universiteit Leuven; Katholieke Universiteit LeuvenNot yet recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2013 Category: Research Source Type: clinical trials
The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit
Condition: Concentration-Time Profiles in Stomach & Intestine.Interventions: Drug: Paromomycin Sulfate Fasted State; Drug: Paromomycin Sulfate Fed State; Drug: Paromomycin Sulfate w/ domperidone; Drug: Paromomycin Sulfate w/ loperamide HClSponsor: Katholieke Universiteit LeuvenRecruiting - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2013 Category: Research Source Type: clinical trials
Efavirenz and Ritonavir on Human Brian P-Glycoprotein
Condition: Drug EffectsInterventions: Drug: [11c] desmethyl-loperamide (dLop); Drug: Ritonavir; Drug: EfavirenzSponsor: Washington University School of MedicineActive, not recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials
Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea
Conditions: Acute Watery Diarrhea; Dysentery/Febrile DiarrheaInterventions: Drug: Single dose rifaximin 1650 mg; Drug: Single dose azithromycin 500 mg; Drug: Single dose levofloxacin 500 mg; Drug: Single dose azithromycin 1000 mg plus loperamide; Drug: Single dose azithromycin 1000 mg plus placeboSponsors: Uniformed Services University of the Health Sciences; Navy Bureau of Medicine and Surgery; United Kingdom Ministry of Defence; Naval Medical Research Center; Naval Medical Research Unit- 3; United States Army Medical Unit - Kenya; United...
Source: ClinicalTrials.gov - June 1, 2012 Category: Research Source Type: clinical trials
Imodium Syrup Versus Imodium Tablets for Faecal Incontinence
Condition: Fecal IncontinenceInterventions: Drug: Imodium (Loperamide Hydrochloride) syrup; Drug: Imodium (Loperamide hydrochloride) tabletsSponsors: University Hospital Southampton NHS Foundation Trust.; University of SouthamptonWithdrawn - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2009 Category: Research Source Type: clinical trials
